Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Roy M. Matining"'
Autor:
Ayana E Morales, Ruby Gumenick, Caitlyn M Genovese, Yun Yeong Jang, Ariene Ouedraogo, Maite Ibáñez de Garayo, Tania Pannellini, Sanjay Patel, Matthew E Bott, Julio Alvarez, Sung Soo Mun, Jennifer Totonchy, Archana Gautam, Jesus Delgado de la Mora, Stephanie Chang, Dagmar Wirth, Marcelo Horenstein, Tao Dao, David A Scheinberg, Paul G Rubinstein, Aggrey Semeere, Jeffrey Martin, Catherine C Godfrey, Carlee B Moser, Roy M Matining, Thomas B Campbell, Margaret Z Borok, Susan E Krown, Ethel Cesarman
Publikováno v:
PLoS Pathogens, Vol 20, Iss 1, p e1011881 (2024)
In people living with HIV, Kaposi Sarcoma (KS), a vascular neoplasm caused by KS herpesvirus (KSHV/HHV-8), remains one of the most common malignancies worldwide. Individuals living with HIV, receiving otherwise effective antiretroviral therapy, may p
Externí odkaz:
https://doaj.org/article/fd71de1d5afd411097ac26c957e4cecc
Publikováno v:
Open Forum Infectious Diseases. 10
Background Long-term outcome data after hepatitis C virus (HCV) treatment are limited, particularly for comparisons between persons with and without HIV. Methods A5320 was a prospective cohort study that enrolled participants within 12 months of comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d43fb74b9eba0eacaa31df72437479
https://doi.org/10.1093/ofid/ofad115
https://doi.org/10.1093/ofid/ofad115
Autor:
Susan E Krown, Carlee B Moser, Patrick MacPhail, Roy M Matining, Catherine Godfrey, Stephanie R Caruso, Mina C Hosseinipour, Wadzanai Samaneka, Mulinda Nyirenda, Naftali W Busakhala, Fred M Okuku, Josphat Kosgei, Brenda Hoagland, Noluthando Mwelase, Vincent O Oliver, Henriette Burger, Rosie Mngqibisa, Mostafa Nokta, Thomas B Campbell, Margaret Z Borok, Agnes Moses, Cecilia Kanyama, Pamela Mukwekwerere, Ivy Gudza, Felluna Chauwa, Godwin Ulaya, Irene Kutto, Priscilla Cheruiyot, Clement Okello, Annet Nakaganda, Geoffrey Koskei, Winnie Keter, Juliana Netto, Tamiris Baião, Iveshni Govender, Jessica O'Connell-Maritz, Kevin Cain, John Okanda, Lynne Cornelissen, Marije Van Schalkwyk, Rejoice Sikhosana, Minenhle Ngcobo, Jeannette Y. Lee, Taylor Harrison, William Wachsman, Katherine Shin, Scott Evans, Jennifer Rothenberg, Lara Hosey, Sean McCarthy, Otoniel Martinez-Maza, Charles Rinaldo, Dirk Dittmer, Courtney Fletcher, Michelle Rudek, Aida Asmelash, Valery Hughes, Jeffrey Schouten, David Shugarts, Tapiwanashe Kujinga, Amanda Zadzilka, Fredrick Kerui, Debora Robertson, James Rooney, Krishna Sewal, Brian Gottshall
Publikováno v:
The Lancet. 395:1195-1207
Summary Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not been systematically evaluated in low-income and middle-income countries, where the dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08bb62a17bbb36e440eb3bae3392271
https://doi.org/10.1016/s0140-6736(19)33222-2
https://doi.org/10.1016/s0140-6736(19)33222-2
Publikováno v:
Open Forum Infectious Diseases
Final results from the long-term Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) found low rates of hepatitis C virus (HCV) recurrence after direct-acting antiviral therapy in both HCV/human immunodeficiency virus (HIV)–coinfected (0.67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28889a26455a52232649daf0db185e8
https://doi.org/10.1093/ofid/ofab511
https://doi.org/10.1093/ofid/ofab511
Autor:
Puja Van Epps, Roy M Matining, Katherine Tassiopoulos, Donald D Anthony, Alan Landay, Robert C Kalayjian, David H Canaday
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107064 (2014)
Older HIV infected subjects were previously found to have significant B cell expansion during initial antiretroviral therapy in a prospective age-differentiated cohort of older and younger (≥45 vs. ≤30 years) HIV-infected subjects initiating anti
Externí odkaz:
https://doaj.org/article/7fe05ffa3c83431f8d54fcb826658cff
Autor:
David B. Clifford, Charles Flexner, Minhee Kang, Daniel C. Douek, Lynette Purdue, Alan L. Landay, Sarah W. Read, Jeffrey M. Jacobson, Princy Kumar, Brian Clagett, Laurie Myers, Michael M. Lederman, Pablo F. Belaunzarán-Zamudio, Steven E. Bosinger, Cara C. Wilson, Pablo Tebas, Roy M. Matining, Guido Silvestri, Linda Boone, Jill Plants
Publikováno v:
AIDS Research and Human Retroviruses. 32:636-647
Immune activation associated with HIV-1 infection contributes to morbidity and mortality. We studied whether chloroquine, through Toll-like receptor (TLR) antagonist properties, could reduce immune activation thought to be driven by TLR ligands, such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::814fde5bb620a0a3a2df3abc6eb2287e
https://doi.org/10.1089/aid.2015.0336
https://doi.org/10.1089/aid.2015.0336
Autor:
Jeffrey M, Jacobson, Lu, Zheng, Cara C, Wilson, Pablo, Tebas, Roy M, Matining, Michael A, Egan, John, Eldridge, Alan L, Landay, David B, Clifford, Anne F, Luetkemeyer, Jennifer, Tiu, Ana L, Martinez, Jennifer, Janik, Teresa A, Spitz, John, Hural, Juliana, McElrath, Nicole, Frahm, Carl J, Fichtenbaum
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 71:163-171
BACKGROUND Therapeutic vaccination is being studied in eradication and "functional cure" strategies for HIV-1. The Profectus Biosciences multiantigen (MAG) HIV-1 DNA vaccine encodes HIV-1 Gag/Pol, Nef/Tat/Vif, and Envelope, and interleukin-12 (IL-12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d6ac8fca29fa17c53ddc38d4657721
https://doi.org/10.1097/qai.0000000000000830
https://doi.org/10.1097/qai.0000000000000830
Autor:
Marion G. Peters, Vhics Study Team, Roy M. Matining, David L. Wyles, Robert L. Murphy, Minhee Kang
Publikováno v:
Open Forum Infectious Diseases
Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1759e97a18119e12e5507a66cd5f97e
https://doi.org/10.1093/ofid/ofy103
https://doi.org/10.1093/ofid/ofy103
Autor:
David L. Wyles, Marshall J. Glesby, Gene D. Morse, Flossie Wong-Staal, Victoria A. Johnson, Valerianna Amorosa, Debika Bhattacharya, Roy M. Matining, Minhee Kang, Mark S. Sulkowski, Kristine Coughlin
Publikováno v:
The Journal of Infectious Diseases. 209:658-667
Chronic hepatitis C virus (HCV) infection is a major cause of liver-related morbidity and mortality due to cirrhosis and hepatocellular carcinoma (HCC) [1]. Current HCV therapy is suboptimal due to toxicity, lack of broad efficacy, and poor complianc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d91dc353501fd6387d3fc3f061bff44
https://doi.org/10.1093/infdis/jit503
https://doi.org/10.1093/infdis/jit503
Autor:
Roy M. Matining, Barry H. Gross, Susan A. Fiscus, Isaac R. Francis, Alan L. Landay, Robert C. Kalayjian, Richard B. Pollard, John Spritzler, Michael M. Lederman
Publikováno v:
AIDS. 27:1563-1571
The contribution of immune activation to accelerated HIV-disease progression in older individuals has not been delineated.Prospective multicenter cohort of older (≥45 years) and younger (18-30 years) HIV-infected adults initiating 192 weeks of anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf79b0e7b70e38591bc5929c95f1062a
https://doi.org/10.1097/qad.0b013e32835fabc2
https://doi.org/10.1097/qad.0b013e32835fabc2